Analysts fret about DRL’s prospects, slash targets Mumbai: Shares of Dr Reddy's Laboratories tanked nearly 7% Thursday, its biggest… Read More...
Dr Reddy’s tumbles 7% post Q4 results! Here’s what… Shares of Dr Redyy's Laboratories (DRL) tumbled nearly 7% to Rs 4,545 in Thursday's… Read More...
Big Movers on D-St: What should investors do with MindTree, DRL and… The Indian market closed in the red for the third consecutive day on Wednesday. The… Read More...
Kunal Bothra’s market outlook & two stock picks for next week Friday’s move compliments data points on the indices. We also saw a blend of short… Read More...
What CLSA says on Lupin; Morgan Stanley on DRL, Godrej Consumer Foreign brokerage CLSA has downgraded to 'underperform' while Morgan Stanley has… Read More...
New initiatives, faster Sputnik rollout can lift DRL The company’s management has also alluded to DRL experimenting with forays into… Read More...
